Orbifloxacin
![]() | |
Systematic (IUPAC) name | |
---|---|
1-Cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status |
|
Identifiers | |
CAS Number |
113617-63-3 ![]() |
ATCvet code | QJ01MA95(WHO) |
PubChem | CID 60605 |
ChemSpider |
54631 ![]() |
UNII |
660932TPY6 ![]() |
KEGG |
D08299 ![]() |
ChEMBL |
CHEMBL295433 ![]() |
Chemical data | |
Formula | C19H20F3N3O3 |
Molar mass | 395.37 g/mol |
| |
| |
![]() ![]() |
Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1] marketed by Schering-Plough Animal Health.
See also
References
- ↑ Product Abstract - NADA 141-081. Retrieved on June 23, 2008.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.